Stable gene silencing by RNA interference (RNAi) can be achieved by expression of small hairpin RNAs (shRNAs) from RNA polymerase III promoters. We have tested lentiviral vectors expressing shRNAs targetting CCR5 in primary CD4 T cells from donors representing various CCR5 and CCR2 genetic backgrounds covering the full spectrum of CCR5 expression levels and permissiveness for HIV-1 infection. A linear decrease in CCR5 expression resulted in a logarithmic decrease in cellular infection, giving up to three logs protection from HIV-1 infection in vitro. Protection was maintained at very high multiplicity of infection. This and other recent reports on RNAi should open a debate about the use of RNAi gene therapy for HIV infection.
References
1.
FireA., XuS., MontgomeryM.K., KostasS.A., DriverS.E., & MelloC.C.Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.Nature1998; 391: 806–811.
2.
ElbashirS.M., HarborthJ., LendeckelW., YalcinA., WeberK., & TuschlT.Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature2001; 411: 494–498.
3.
LeeN.S., DohjimaT., BauerG., LiH., LiM.J., EhsaniA., SalvaterraP., & RossiJ.Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nature Biotechnology2002; 20: 500–505.
CapodiciJ., KarikoK., & WeissmanD.Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference. Journal of Immunology2002; 169: 5196–5201.
6.
CoburnG.A., & CullenB.R.Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. Journal of Virology2002; 76: 9225–9231.
7.
JacqueJ.M., TriquesK., & StevensonM.Modulation of HIV-1 replication by RNA interference. Nature2002; 418: 435–438.
8.
ParkW.S., Miyano-KurosakiN., HayafuneM., NakajimaE., MatsuzakiT., ShimadaF., & TakakuH.Prevention of HIV-1 infection in human peripheral blood mononuclear cells by specific RNA interference. Nucleic Acids Research2002; 30: 4830–4835.
9.
SurabhiR.M., & GaynorR.B.RNA interference directed against viral and cellular targets inhibits human immunodeficiency virus Type 1 replication. Journal of Virology2002; 76: 12963–12973.
10.
ArteagaH.J., HinkulaJ., Dijk-HardI., DilberM.S., WahrenB., ChristenssonB., MohamedA.J., & Edvard SmithC.I.Choosing CCR5 or Rev siRNA in HIV-1. Nature Biotechnology2003; 21: 230–231.
11.
MartinezM.A., GutierrezA., Armand-UgonM., BlancoJ., PareraM., GomezJ., ClotetB., & EsteJ.A.Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication. AIDS2002; 16: 2385–2390.
12.
GarrusJ.E., von SchwedlerU.K., PornillosO.W., MorhamS.G., ZavitzK.H., WangH.E., WettsteinD.A., StrayK.M., CoteM., RichR.L., MyszkaD.G., & SundquistW.I.Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell2001; 107: 55–65.
13.
BartonG.M., & MedzhitovR.Retroviral delivery of small interfering RNA into primary cells. Proceedings of the National Academy of Sciences, USA2002; 99: 14943–14945.
14.
BridgeA.J., PebernardS., DucrauxA., NicoulazA.L., & IggoR.Induction of an interferon response by RNAi vectors in mammalian cells. Nature Genetics2003; 34: 263–264.
15.
QinX.F., AnD.S., ChenI.S., & BaltimoreD.Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proceedings of the National Academy of Sciences, USA2003; 100: 183–188.
16.
PauleM.R., & WhiteR.J.Survey and summary: transcription by RNA polymerases I and III. Nucleic Acids Research2000; 28: 1283–1298.
17.
BrummelkampT.R., BernardsR., & AgamiR.A system for stable expression of short interfering RNAs in mammalian cells. Science2002; 296: 550–553.
18.
VenkatesanS., PetrovicA., Van RykD.I., LocatiM., WeissmanD., & MurphyP.M.Reduced cell surface expression of CCR5 in CCR5Delta 32 heterozygotes is mediated by gene dosage, rather than by receptor sequestration. Journal of Biological Chemistry2002; 277: 2287–2301.
19.
LeeB., SharronM., MontanerL.J., WeissmanD., & DomsR.W.Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proceedings of the National Academy of Sciences, USA1999; 96: 5215–5220.
20.
RubinsonD.A., DillonC.P., KwiatkowskiA.V., SieversC., YangL., KopinjaJ., ZhangM., McManusM.T., GertlerF.B., ScottM.L., & Van ParijsL.A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nature Genetics2003; 33: 401–406.
21.
Hacein-Bey-AbinaS., von KalleC., SchmidtM., Le DeistF., WulffraatN., McIntyreE., RadfordI., VillevalJ.L., FraserC.C., Cavazzana-CalvoM., & FischerA.A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. New England Journal of Medicine2003; 348: 255–256.
